Bacterial cell wall peptidoglycan synthesis machinery (PG synthesis machinery)

The bacterial cell wall peptidoglycan synthesis machinery is a complex, multi-stage enzymatic system responsible for the assembly of the peptidoglycan (murein) layer, which provides structural integrity and osmotic protection to the bacterial cell [1.1.1, 1.3.2]. This machinery comprises three distinct phases: the cytoplasmic phase involving Mur enzymes (MurA-F) that synthesize nucleotide-linked precursors; the membrane-associated phase where MraY and MurG assemble Lipid I and II, followed by flippases like MurJ; and the periplasmic phase where penicillin-binding proteins (PBPs) and SEDS proteins catalyze glycan polymerization and peptide cross-linking [1.1.3, 1.3.3]. As peptidoglycan is essential for bacterial survival and absent in human cells, it serves as a primary target for numerous antibiotic classes, including beta-lactams, glycopeptides, and phosphonates [1.2.1, 1.5.2]. These drugs disrupt various steps of the machinery, leading to cell wall weakening, arrest of cell division, and eventual osmotic lysis [1.4.3, 1.5.3]. Despite its historical success as a target, the machinery is subject to diverse resistance mechanisms, such as target modification and enzymatic drug degradation, necessitating the ongoing development of inhibitors for novel enzymatic nodes within the pathway [1.1.1, 1.5.2].

Other names

Peptidoglycan biosynthesis pathwayMurein synthesis machineryCell wall synthesis machineryPeptidoglycan sacculus assembly machineryBacterial cell wall biosynthetic process

Inhibition of transpeptidation by binding to penicillin-binding proteins (PBPs), sequestration of Lipid II precursors by binding to D-Ala-D-Ala termini, inhibition of early precursor synthesis (MurA), and disruption of lipid carrier recycling [1.1.1, 1.1.5, 1.5.2].